|
Market Closed -
BME
09:05:01 12/08/2026 pm IST
|
After hours 10:17:04 pm | |||
| 57.80 EUR | -0.94% |
|
57.82 | +0.04% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
EPS & Dividend: Laboratorios Farmaceuticos Rovi, S.A.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 0.9556 | 1.294 | 1.104 | 0.9351 | 0.9594 | 0.963 | 1.169 | 1.354 |
| Rate of return | 1.29% | 3.59% | 1.83% | 1.49% | 1.51% | 1.65% | 2% | 2.32% |
| EPS 2 | 2.76 | 3.73 | 3.2 | 2.67 | 2.75 | 2.795 | 3.388 | 4.146 |
| Distribution rate | 34.6% | 34.7% | 34.5% | 35% | 34.9% | 34.5% | 34.5% | 32.6% |
| Reference price 2 | 73.80 | 36.06 | 60.20 | 62.95 | 63.50 | 58.35 | 58.35 | 58.35 |
| Nbr of stocks (in thousands) | 56,069 | 53,375 | 53,370 | 51,149 | 51,149 | 51,143 | - | - |
| Announcement Date | 23/02/22 | 21/02/23 | 27/02/24 | 25/02/25 | 24/02/26 | - | - | - |
1EUR in Million2EUR
Estimates
Past dividends: Laboratorios Farmaceuticos Rovi, S.A.
| 13/07/2026 | Ex-dividend date - 0.77711 EUR | 09:30 am |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.65% | 2% | 20.87x | 4x | 3.85x | |
| 0.57% | 0.63% | 34.45x | 21.73x | 12.59x | |
| 2.07% | 2.17% | 28.9x | - | - | |
| 2.74% | 2.88% | 31.93x | 2383.63x | 7.43x | |
| 2.71% | 2.77% | 20.56x | 7.38x | 4.87x | |
| 2.82% | 2.94% | 22.02x | 6.2x | 5.7x | |
| 2.08% | 2.2% | 20.5x | 4.6x | 4.23x | |
| 2.43% | 2.57% | 25.99x | 19.59x | 6.83x | |
| 3.65% | 3.62% | 13.93x | 5.84x | 4.99x | |
| 2.43% | 2.51% | -42.16x | 8.38x | 6.03x | |
| Average | 2.31% | 2.43% | 17.70x | 273.48x | 6.28x | |
| Weighted average by Cap. | 1.96% | 2.05% | 24.65x | 358.85x | 8.24x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
